Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
00:00
Intro
This chapter explores the global issue of obesity, emphasizing its recognition as a complex disease influenced by various factors like genetics and food accessibility. The speakers discuss the shortcomings of past medical approaches and highlight advancements in treatment stemming from decades of research.
Play episode from 00:00
Transcript
